BioCryst More Than Doubles Q3 2026 Net Income
Story updates
12:19:31 PM UTC
SquawkNews
BioCryst Q3 2026 net income more than doubles to $37.92 million BioCryst Pharmaceuticals’ third
Related stories
Grainger Raises 2026 Adjusted EPS Guidance
W.W. Grainger raised its 2026 adjusted earnings-per-share guidance.
M impact | EARNINGS | Nov 04, 2026, 01:35 PM UTC
Mayur Uniquoters reports September-quarter revenue of 2.83 bln rupees
L impact | EARNINGS | Nov 04, 2026, 01:26 PM UTC
Mayur Uniquoters Reports September-Quarter Net Profit of 579.9 Million Rupees
M impact | EARNINGS | Nov 04, 2026, 01:26 PM UTC
Mediocredito Centrale Reports Stable Nine-Month Net Profit; Lending Increases
Mediocredito Centrale reported stable net profit for the first nine months and an increase in lending.
M impact | EARNINGS | Nov 04, 2026, 01:26 PM UTC
Enkei Wheels Reports September-Quarter Profit of 72.8 Million Rupees
L impact | EARNINGS | Nov 04, 2026, 01:26 PM UTC
The Andersons Q3 2026 Diluted EPS More Than Doubles to $1.36
M impact | EARNINGS | Nov 04, 2026, 01:25 PM UTC